BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Badri PS, Parikh A, Coakley EP, Ding B, Awni WM, Dutta S, Menon RM. Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection. Ther Drug Monit. 2016;38:640-645. [PMID: 27310199 DOI: 10.1097/ftd.0000000000000315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Forns X, Navasa M. Liver transplant immunosuppression during the covid-19 pandemic. Gastroenterol Hepatol 2020;43:457-63. [PMID: 32646657 DOI: 10.1016/j.gastrohep.2020.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Naccarato M, Kwee F, Zaltzman J, Fong IW. Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction? AIDS 2021;35:2065-8. [PMID: 34471078 DOI: 10.1097/QAD.0000000000003002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mirjalili M, Shafiekhani M, Vazin A. Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Ther Clin Risk Manag 2020;16:617-29. [PMID: 32694915 DOI: 10.2147/TCRM.S256246] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
4 Badri PS, Shuster DL, Dutta S, Menon RM. Clinical Pharmacokinetics of Ombitasvir. Clin Pharmacokinet 2017;56:1103-13. [PMID: 28229375 DOI: 10.1007/s40262-017-0518-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Menon RM, Polepally AR, Khatri A, Awni WM, Dutta S. Clinical Pharmacokinetics of Paritaprevir. Clin Pharmacokinet 2017;56:1125-37. [PMID: 28236252 DOI: 10.1007/s40262-017-0520-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
6 Nanga TM, Doan TTP, Marquet P, Musuamba FT. Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach. Br J Clin Pharmacol 2019;85:2793-823. [PMID: 31471970 DOI: 10.1111/bcp.14110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
7 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]